Alwyn Company has conducted an extensive series of safety studies at GLP-compliant contract facilities. Alwyn Cream demonstrated no clinically significant potential for eliciting either dermal irritation or sensitization. Alwyn Cream is not a primary dermal irritant.
Physicians and health care professionals may obtain detailed information by contacting Mark Herll at Alwyn Company. Mark can be reached at mherll@alwyn.com.